Skip to content

Multi omics screening of therapeutic targets for age-related dry eye and study on the therapeutic effect and mechanism of chrysanthemum

Multi omics screening of therapeutic targets for age-related dry eye and study on the therapeutic effect and mechanism of chrysanthemum

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100993
Enrollment
Unknown
Registered
2025-04-17
Start date
2024-09-11
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related dry eye

Interventions

Dry eye treatment group:Twenty subjects with age-related dry eye were given sodium hyaluronate eye drops four times a day, 1-2 drops each time, applied to the eyelids. Take chrysanthemum granules in c
Dry eye contral group:Twenty subjects with age-related dry eye were given sodium hyaluronate eye drops to the affected eyes, 4 times a day, 1-2 drops each time, applied to the eyelids, and continuousl
Youth group without dry eye:None
Elderly group without dry eye:None

Sponsors

The First Hospital of Hunan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria for young people without dry eyes (1) When signing the informed consent form, the age range is 18-30 years old (including 18 and 30 years old), and there is no gender limit; (2) Prior to conducting any research related procedures, an informed consent form must be signed; (3) Excluding dry eyes, there are no other eye diseases; (4) Good compliance, capable of completing this study; (5) According to the researchers' assessment, the anatomical structure of the eyelids is normal. (6) Testosterone in the blood is at normal levels. Inclusion criteria for elderly people without dry eyes (1) When signing the informed consent form, the age range is 60-80 years old (including 60 and 80 years old), and there is no gender restriction; (2) Prior to conducting any research related procedures, an informed consent form must be signed; (3) Excluding dry eyes, there are no other eye diseases; (4) Good compliance, capable of completing this study; (5) According to the researchers' assessment, the anatomical structure of the eyelids is normal; (6) Testosterone in the blood is at normal levels. Inclusion criteria for age-related dry eye population (1) When signing the informed consent form, the age range is 60-80 years old (including 60 and 80 years old), and there is no gender restriction; (2) Prior to conducting any research related procedures, an informed consent form must be signed; (3) Meets the diagnostic criteria for dry eye and has no comorbidities of other eye diseases; (4) Good compliance, capable of completing this study; (5) There are no systemic diseases such as Sjogren's syndrome or Steven Johnson syndrome that can cause dry eye; (6) According to the researchers' assessment, the anatomical structure of the eyelids is normal; (7) Testosterone levels in the blood are lower than normal.

Exclusion criteria

Exclusion criteria: (1) Long eye axis (>26mm) and short eye axis (-6.0D; (2) Abnormal anterior segment examination (including closed corner examination); (3) History of other organic eye diseases and systemic corticosteroid use; (4) Individuals with a history of eye surgery or planning to undergo surgical treatment during the study period; (5) Either eye has a history of poorly controlled glaucoma, or either eye is receiving eye drops for glaucoma treatment; (6) There are serious systemic diseases, such as uncontrollable hypertension, diabetes, etc; (7) Have a known history of drug dependence, drug abuse, or drug use within the past 5 years; (8) Patients who are unable to use the investigational drug as required; (9) Participants in other clinical trials within 3 months prior to the start of this trial; (10) Researchers believe that participants are not suitable for the trial due to other reasons.

Design outcomes

Primary

MeasureTime frame
Serum protein composition;

Secondary

MeasureTime frame
Serum metabolites composition;Protein components of tears;Metabolites in tears;Schirmer test ;Break-up time(BUT);Corneal fluorescence staining;

Countries

China

Contacts

Public ContactXiaolei Yao

The First Hospital of Hunan University of Chinese Medicine

yxlshh@126.com+86 136 7738 0403

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026